Stiolto Respimat (tiotropium bromide/olodaterol) has just been approved by the FDA for the maintenance treatment of COPD, and should be available in pharmacies soon.
Striverdi (olodaterol) is used to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis or emphysema. Striverdi is less popular than other long-acting beta agonists. There are currently no generic alternatives to Striverdi.
Check our savings tips for co-pay cards, assistance programs, and other ways to reduce your cost. Striverdi is covered by most Medicare and insurance plans.
Olodaterol Latest News
Get the latest updates on this drug from the GoodRx medical team